KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Retained Earnings (2018 - 2026)

Takeda Pharmaceutical has reported Retained Earnings over the past 9 years, most recently at $6.7 billion for Q1 2026.

  • For Q1 2026, Retained Earnings fell 13.45% year-over-year to $6.7 billion; the TTM value through Mar 2026 reached $6.7 billion, down 13.45%, while the annual FY2026 figure was $7.0 billion, 9.97% down from the prior year.
  • Retained Earnings was $6.7 billion for Q1 2026 at Takeda Pharmaceutical, down from $7.8 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at $12.7 billion in Q1 2022 and bottomed at $6.7 billion in Q1 2026.
  • The 5-year median for Retained Earnings is $9.4 billion (2024), against an average of $9.7 billion.
  • Year-over-year, Retained Earnings dropped 8.5% in 2023 and then dropped 19.43% in 2024.
  • Over 5 years, Retained Earnings stood at $12.7 billion in 2022, then decreased by 8.5% to $11.7 billion in 2023, then dropped by 19.43% to $9.4 billion in 2024, then dropped by 17.08% to $7.8 billion in 2025, then dropped by 13.45% to $6.7 billion in 2026.
  • The last three reported values for Retained Earnings were $6.7 billion (Q1 2026), $7.8 billion (Q1 2025), and $9.4 billion (Q1 2024) per Business Quant data.